Ozempic est lié à un risque accru de cécité
De : https://articles.mercola.com/sites/articles/archive/2024/09/07/ozempic-linked-increased-risk-blindness.aspx Traduction automatique ici : https://translate.google.com/website?sl=hl&en=fr&hl=fr&u=https://etouffoir.blogspot.com/2024/09/ozempic-est-lie-un-risque-accru-de.html Ozempic Linked to Increased Risk of Blindness Analysis by Dr. Joseph Mercola 7 septembre 2024 Story at-a-glance Ozempic and Wegovy, GLP-1 receptor agonists, are successful weight loss drugs. However, research suggests they may increase the risk of gastrointestinal issues and potentially impact vision that may lead to blindness A 2024 study found an association between semaglutide (Ozempic) and non-arteritic anterior ischemic optic neuropathy (NAION) in diabetic and obese patients, potentially leading to sudden vision loss GLP-1 receptor agonists may also increase risks of gastroparesis, biliary disease, pancreatitis, bowel obstruction and ot...